106 related articles for article (PubMed ID: 29680317)
1. A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
Battaglini E; Park SB; Barnes EH; Goldstein D
Contemp Clin Trials; 2018 Jul; 70():135-138. PubMed ID: 29680317
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Velasco R; Besora S; Argyriou AA; Santos C; Sala R; Izquierdo C; Simó M; Gil-Gil M; Pardo B; Jiménez L; Clapés V; Calvo M; Palmero R; Bruna J
Anticancer Drugs; 2021 Jan; 32(1):88-94. PubMed ID: 33332891
[TBL] [Abstract][Full Text] [Related]
4. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update.
Desforges AD; Hebert CM; Spence AL; Reid B; Dhaibar HA; Cruz-Topete D; Cornett EM; Kaye AD; Urits I; Viswanath O
Biomed Pharmacother; 2022 Mar; 147():112671. PubMed ID: 35104697
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical Trial.
Aghili M; Darzikolaee NM; Babaei M; Ghalehtaki R; Farhan F; Razavi SZE; Rezaei S; Esmati E; Samiei F; Azadvari M; Farazmand B; Bayani R; Amiri A
J Gastrointest Cancer; 2023 Jun; 54(2):467-474. PubMed ID: 35426033
[TBL] [Abstract][Full Text] [Related]
6. Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH.
Streckmann F; Hess V; Bloch W; Décard BF; Ritzmann R; Lehmann HC; Balke M; Koliamitra C; Oschwald V; Elter T; Zahner L; Donath L; Roth R; Faude O
BMJ Open; 2019 Apr; 9(4):e024467. PubMed ID: 31023750
[TBL] [Abstract][Full Text] [Related]
7. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
[TBL] [Abstract][Full Text] [Related]
8. Identifying trajectories and predictors of chemotherapy-induced peripheral neuropathy symptoms, physical functioning, and falls across treatment and recovery in adults treated with neurotoxic chemotherapy: the PATTERN observational study protocol (NCT05790538).
Winters-Stone KM; Krasnow SM; Horak FB; Mancini M; Cameron MH; Dieckmann NF; Stoyles SA; Roeland EJ
BMC Cancer; 2023 Nov; 23(1):1087. PubMed ID: 37946117
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
Barton DL; Wos EJ; Qin R; Mattar BI; Green NB; Lanier KS; Bearden JD; Kugler JW; Hoff KL; Reddy PS; Rowland KM; Riepl M; Christensen B; Loprinzi CL
Support Care Cancer; 2011 Jun; 19(6):833-41. PubMed ID: 20496177
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
[No Abstract] [Full Text] [Related]
11. Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Proof-of-Concept Randomized Clinical Trial.
Gewandter JS; Culakova E; Davis JN; Gada U; Guido JJ; Bearden JD; Burnette B; Shah D; Morrow GR; Mustian K; Sluka KA; Mohile N
J Pain; 2024 May; 25(5):104431. PubMed ID: 37993030
[TBL] [Abstract][Full Text] [Related]
12. Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain).
Strauss DH; Santhanam DR; McLean SA; Beaudoin FL
BMJ Open; 2019 Mar; 9(3):e025002. PubMed ID: 30842115
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.
Bruna J; Videla S; Argyriou AA; Velasco R; Villoria J; Santos C; Nadal C; Cavaletti G; Alberti P; Briani C; Kalofonos HP; Cortinovis D; Sust M; Vaqué A; Klein T; Plata-Salamán C
Neurotherapeutics; 2018 Jan; 15(1):178-189. PubMed ID: 28924870
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
15. CE: Chemotherapy-Induced Peripheral Neuropathy.
Knoerl R
Am J Nurs; 2021 Apr; 121(4):26-30. PubMed ID: 33735114
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial.
Aghabozorgi R; Hesam M; Zahed G; Babaee M; Hashemi M; Rayegani SM
Anticancer Drugs; 2023 Jun; 34(5):680-685. PubMed ID: 36730548
[TBL] [Abstract][Full Text] [Related]
17. Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
Schaffler-Schaden D; Sassmann R; Johansson T; Gampenrieder SP; Rinnerthaler G; Lampl K; Herfert J; Lenzhofer C; Landkammer YT; Rieder F; Greil R; Flamm M; Niebauer J
Medicine (Baltimore); 2020 May; 99(19):e20149. PubMed ID: 32384502
[TBL] [Abstract][Full Text] [Related]
18. Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial.
Najafi S; Heidarali Z; Rajabi M; Omidi Z; Zayeri F; Salehi M; Haghighat S
Trials; 2021 Nov; 22(1):835. PubMed ID: 34819131
[TBL] [Abstract][Full Text] [Related]
19. Early effects of duloxetine on emotion recognition in healthy volunteers.
Bamford S; Penton-Voak I; Pinkney V; Baldwin DS; Munafò MR; Garner M
J Psychopharmacol; 2015 May; 29(5):634-41. PubMed ID: 25759400
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
Cavaletti G; Marmiroli P; Renn CL; Dorsey SG; Serra MP; Quartu M; Meregalli C
Neurotherapeutics; 2021 Oct; 18(4):2324-2336. PubMed ID: 34668147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]